Luteolin as a glycolysis inhibitor offers superior efficacy and lesser toxicity of doxorubicin in breast cancer cells (Q39978588)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Luteolin as a glycolysis inhibitor offers superior efficacy and lesser toxicity of doxorubicin in breast cancer cells |
scientific article |
Statements
1 reference
Luteolin as a glycolysis inhibitor offers superior efficacy and lesser toxicity of doxorubicin in breast cancer cells (English)
1 reference
Gang-Jun Du
1 reference
Zhi-Hui Song
1 reference
Hai-Hong Lin
1 reference
Xiao-Feng Han
1 reference
Shuo Zhang
1 reference
Yi-Ming Yang
1 reference
27 May 2008
1 reference
1 reference
372
1 reference
3
1 reference
497-502
1 reference
Identifiers
1 reference
1 reference